2,383
Participants
Start Date
March 11, 2022
Primary Completion Date
February 7, 2024
Study Completion Date
February 7, 2024
NeuMoDx™ FluA/FluB/RSV/SARS-CoV-2 Assay
The NeuMoDx™ FluA/FluB/RSV/SARS-CoV-2 Assay (IUO) is a multiplexed, in vitro real-time Polymerase Chain Reaction assay, diagnostic test intended for the simultaneous qualitative detection and differentiation of Influenza A virus (Flu A), Influenza B virus (Flu B), Respiratory Syncytial Virus (RSV) and SARS-CoV-2 RNA
QIAGEN Gaithersburg, Inc, Manchester
QIAGEN Gaithersburg, Inc
INDUSTRY